Tag Archives: Qiagen

Qiagen announces the acquisition of an enabling technology for enrichment and molecular analysis of circulating tumor cells (CTCs) from blood samples

exosome rna

GERMANTOWN, Maryland, and HILDEN, Germany, March 16, 2015 /PRNewswire/ — Acquisition of technology from AdnaGen enables use of innovative, non-invasive blood tests to analyze circulating tumor cells (CTCs) for personalized healthcare QIAGEN and Tokai Pharmaceuticals to co-develop and commercialize the ...

Read More »